secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2025-10-28T23:59:59+00:00
Accession:  0001437749-25-031957
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics Q3 revenue $4.2M (+2% YoY); exploring sale or acquisition of different industry
--------------------------------------------------------------------------------

- Revenue $4.2M, up 2% YoY and 105% sequentially; gross margin 60.3% vs 53.5% last year.
- Net loss narrowed 31% YoY to $1.4M ($0.54/share) from $2.1M ($1.53/share).
- Cash $2.7M as of Sept 30, 2025.
- Company exploring strategic transactions including acquisition of a non-exoskeleton business or sale of substantially all assets.
- Any transaction would require stockholder approval; no timetable set for strategic review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925031957/0001437749-25-031957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925031957/ekso20250806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer